|Articles|August 1, 1998

August 1998
Volume 4
Issue 8

Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

Author(s)Susan D. Horn, PhD, Phoebe D. Sharkey, PhD, Cheryl Phillips-Harris, MD

Download PDF: Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

Articles in this issue

about 28 years ago

Article

The Impact of Reimbursement Changes for Intracoronary Stents on Providers and Medicare

about 28 years ago

Article

The Cost of Inpatient Endometriosis Treatment: An Analysis Based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample

about 28 years ago

Article

Identification and Assessment of High-Risk Seniors

about 28 years ago

Article

Outpatient Antidepressant Utilization in a Dutch Sick Fund

about 28 years ago

Article

Inborn Errors of Metabolism: Medical and Administrative "Orphans"

about 28 years ago

Article

Treatment Options for Prostate Cancer: Part 2 -- Early and Late Stage and Hormone Refractory Disease

about 28 years ago

Article

Generic Drug Product Equivalence: Current Status

about 28 years ago

Article

Correspondence regarding, "A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia"

about 28 years ago

Article

The Clinical Value of Commonly Used Spinal Fluid Diagnostic Studies in the Evaluation of Patients with Suspected Multiple Sclerosis

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

Zanubrutinib Outlasting Acalabrutinib in CLL

FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication

Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care

Experts Weigh Vitiligo's Cosmetic Label as Oral Therapies Near